|
1
|
John N, Eble GS, Jonathan I and Epstein
Isabell A; Sesterhenn World health organization classification of
tumors, . Pathology and genetics of tumors of the urinary system
and male genital organs. IARC Press; Lyon: 2004
|
|
2
|
Hsieh JJ, Purdue MP, Signoretti S, Swanton
C, Albiges L, Schmidinger M, Heng DY, Larkin J and Ficarra V: Renal
cell carcinoma. Nat Rev Dis Primers. 3:170092017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cairns P: Renal cell carcinoma. Cancer
Biomark. 9:461–473. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Inamura K: Renal cell tumors:
Understanding their molecular pathological epidemiology and the
2016 WHO classification. Int J Mol Sci. 18:21952017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nabi S, Kessler ER, Bernard B, Flaig TW
and Lam ET: Renal cell carcinoma: A review of biology and
pathophysiology. F1000Res. 7:3072018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lopez-Beltran A, Scarpelli M, Montironi R
and Kirkali Z: 2004 WHO classification of the renal tumors of the
adults. Eur Urol. 49:798–805. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Prasad SR, Humphrey PA, Catena JR, Narra
VR, Srigley JR, Cortez AD, Dalrymple NC and Chintapalli KN: Common
and uncommon histologic subtypes of renal cell carcinoma: Imaging
spectrum with pathologic correlation. Radiographics. 26:1795–1810.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yap NY, Rajandram R, Ng KL, Pailoor J,
Fadzli A and Gobe GC: Genetic and chromosomal aberrations and their
clinical significance in renal neoplasms. Biomed Res Int.
2015:4765082015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cancer Genome Atlas Research Network, .
Linehan WM, Spellman PT, Ricketts CJ, Creighton CJ, Fei SS, Davis
C, Wheeler DA, Murray BA, Schmidt L, et al: Comprehensive molecular
characterization of papillary renal-cell carcinoma. N Engl J Med.
374:135–145. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rhoades Smith KE and Bilen MA: A review of
papillary renal cell carcinoma and MET inhibitors. Kidney Cancer.
3:151–161. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Vera-Badillo FE, Conde E and Duran I:
Chromophobe renal cell carcinoma: A review of an uncommon entity.
Int J Urol. 19:894–900. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Warren AY and Harrison D: WHO/ISUP
classification, grading and pathological staging of renal cell
carcinoma: Standards and controversies. World J Urol. 36:1913–1926.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Frew IJ and Moch H: A clearer view of the
molecular complexity of clear cell renal cell carcinoma. Annu Rev
Pathol. 10:263–289. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Moch H, Cubilla AL, Humphrey PA, Reuter VE
and Ulbright TM: The 2016 WHO classification of tumours of the
urinary system and male genital organs-part A: Renal, penile, and
testicular tumours. Eur Urol. 70:93–105. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
WHO Classification of Tumours Editorial
Board, Urinary and male genital tumours and WHO Classification of
Tumours, . 5th edition. 8. World Health Organization; 2022
|
|
16
|
Delahunt B, Srigley JR, Montironi R and
Egevad L: Advances in renal neoplasia: Recommendations from the
2012 international society of urological pathology consensus
conference. Urology. 83:969–974. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Srigley JR, Delahunt B, Eble JN, Egevad L,
Epstein JI, Grignon D, Hes O, Moch H, Montironi R, Tickoo SK, et
al: The international society of urological pathology (ISUP)
vancouver classification of renal neoplasia. Am J Surg Pathol.
37:1469–1489. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Moch H: The WHO/ISUP grading system for
renal carcinoma. Pathologe. 37:355–360. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Trpkov K and Hes O: New and emerging renal
entities: A perspective post-WHO 2016 classification.
Histopathology. 74:31–59. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Delahunt B, Cheville JC, Martignoni G,
Humphrey PA, Magi-Galluzzi C, McKenney J, Egevad L, Algaba F, Moch
H, Grignon DJ, et al: The international society of urological
pathology (ISUP) grading system for renal cell carcinoma and other
prognostic parameters. Am J Surg Pathol. 37:1490–1504. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen YB, Xu J, Skanderup AJ, Dong Y,
Brannon AR, Wang L, Won HH, Wang PI, Nanjangud GJ, Jungbluth AA, et
al: Molecular analysis of aggressive renal cell carcinoma with
unclassified histology reveals distinct subsets. Nat Commun.
7:131312016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Trpkov K, Williamson SR, Gill AJ, Adeniran
AJ, Agaimy A, Alaghehbandan R, Amin MB, Argani P, Chen YB, Cheng L,
et al: Novel, emerging and provisional renal entities: The
genitourinary pathology society (GUPS) update on renal neoplasia.
Mod Pathol. 34:1167–1184. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li Y, Reuter VE, Matoso A, Netto GJ,
Epstein JI and Argani P: Re-evaluation of 33 ‘unclassified’
eosinophilic renal cell carcinomas in young patients.
Histopathology. 72:588–600. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Eble JN and Delahunt B: Emerging entities
in renal cell neoplasia: Thyroid-like follicular renal cell
carcinoma and multifocal oncocytoma-like tumours associated with
oncocytosis. Pathology. 50:24–36. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Williamson SR, Kum JB, Goheen MP, Cheng L,
Grignon DJ and Idrees MT: Clear cell renal cell carcinoma with a
syncytial-type multinucleated giant tumor cell component:
Implications for differential diagnosis. Hum Pathol. 45:735–744.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Robila V, Kraft AO and Smith SC: New
entities, new technologies, new findings: A review of the cytologic
features of recently established subtypes of renal cell carcinoma.
Cancer Cytopathol. 127:79–97. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Stratton KL, Alanee S, Glogowski EA,
Schrader KA, Rau-Murthy R, Klein R, Russo P, Coleman J and Offit K:
Outcome of genetic evaluation of patients with kidney cancer
referred for suspected hereditary cancer syndromes. Urol Oncol.
34:238.e1–e7. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yunker A, Holder L and Nething J: Newly
described eosinophilic, solid and cystic renal cell carcinoma: A
case report and review of the literature. Arch Nephrol Urol.
3:38–45. 2020. View Article : Google Scholar
|
|
29
|
Samaratunga H, Gianduzzo T and Delahunt B:
The ISUP system of staging, grading and classification of renal
cell neoplasia. J Kidney Cancer VHL. 1:26–39. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fuhrman SA, Lasky LC and Limas C:
Prognostic significance of morphologic parameters in renal cell
carcinoma. Am J Surg Pathol. 6:655–663. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Delahunt B: Advances and controversies in
grading and staging of renal cell carcinoma. Mod Pathol. 22 (Suppl
2):S24–S36. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Delahunt B, Eble JN, Egevad L and
Samaratunga H: Grading of renal cell carcinoma. Histopathology.
74:4–17. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Swami U, Nussenzveig RH, Haaland B and
Agarwal N: Revisiting AJCC TNM staging for renal cell carcinoma:
Quest for improvement. Ann Transl Med. 7 (Suppl 1):S182019.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Paner GP, Stadler WM, Hansel DE, Montironi
R, Lin DW and Amin MB: Updates in the eighth edition of the
tumor-node-metastasis staging classification for urologic cancers.
Eur Urol. 73:560–569. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Amin MB, Greene FL, Edge SB, Compton CC,
Gershenwald JE, Brookland RK, Meyer L, Gress DM, Byrd DR and
Winchester DP: The eighth edition AJCC cancer staging manual:
Continuing to build a bridge from a population-based to a more
‘personalized’ approach to cancer staging. CA Cancer J Clin.
67:93–99. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Qayyum T, McArdle P, Orange C, Seywright
M, Horgan P, Oades G, Aitchison M and Edwards J: Reclassification
of the Fuhrman grading system in renal cell carcinoma-does it make
a difference? Springerplus. 2:3782013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Khor LY, Dhakal HP, Jia X, Reynolds JP,
McKenney JK, Rini BI, Magi-Galluzzi C and Przybycin CG: Tumor
necrosis adds prognostically significant information to grade in
clear cell renal cell carcinoma: A study of 842 consecutive cases
from a single institution. Am J Surg Pathol. 40:1224–1231. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Avulova S, Cheville JC, Lohse CM, Gupta S,
Potretzke TA, Tsivian M, Thompson RH, Boorjian SA, Leibovich BC and
Potretzke AM: Grading chromophobe renal cell carcinoma: Evidence
for a four-tiered classification incorporating coagulative tumor
necrosis. Eur Urol. 79:225–231. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhang L, Zha Z, Qu W, Zhao H, Yuan J, Feng
Y and Wu B: Tumor necrosis as a prognostic variable for the
clinical outcome in patients with renal cell carcinoma: A
systematic review and meta-analysis. BMC Cancer. 18:8702018.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Belsante M, Darwish O, Youssef R, Bagrodia
A, Kapur P, Sagalowsky AI, Lotan Y and Margulis V: Lymphovascular
invasion in clear cell renal cell carcinoma-association with
disease-free and cancer-specific survival. Urol Oncol.
32:30.e23–e8. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Delahunt B, Srigley JR, Judge M, Amin M,
Billis A, Camparo P, Fleming S, Griffiths D, Lopez-Beltran A,
Martignoni G, et al: Dataset for the reporting of renal biopsy for
tumour: Recommendations from the international collaboration on
cancer reporting (ICCR). J Clin Pathol. 72:573–578. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Joosten SC, Odeh SNO, Koch A, Buekers N,
Aarts MJB, Baldewijns MMLL, Van Neste L, van Kuijk S, Schouten LJ,
van den Brandt PA, et al: Development of a prognostic risk model
for clear cell renal cell carcinoma by systematic evaluation of DNA
methylation markers. Clin Epigenetics. 13:1032021. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
van Vlodrop IJH, Joosten SC, De Meyer T,
Smits KM, Van Neste L, Melotte V, Baldewijns MMLL, Schouten LJ, van
den Brandt PA, Jeschke J, et al: A four-gene promoter methylation
marker panel consisting of GREM1, NEURL, LAD1, and NEFH predicts
survival of clear cell renal cell cancer patients. Clin Cancer Res.
23:2006–2018. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Deckers IA, van Engeland M, van den Brandt
PA, Van Neste L, Soetekouw PM, Aarts MJ, Baldewijns MM, Keszei AP
and Schouten LJ: Promoter CpG island methylation in ion transport
mechanisms and associated dietary intakes jointly influence the
risk of clear-cell renal cell cancer. Int J Epidemiol. 46:622–631.
2017.PubMed/NCBI
|
|
45
|
van Houwelingen KP, van Dijk BA,
Hulsbergen-van de Kaa CA, Schouten LJ, Gorissen HJ, Schalken JA,
van den Brandt PA and Oosterwijk E: Prevalence of von Hippel-Lindau
gene mutations in sporadic renal cell carcinoma: Results from The
Netherlands cohort study. BMC Cancer. 5:572005. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
van den Brandt PA, Goldbohm RA, van't Veer
P, Volovics A, Hermus RJ and Sturmans F: A large-scale prospective
cohort study on diet and cancer in The Netherlands. J Clin
Epidemiol. 43:285–295. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Casparie M, Tiebosch AT, Burger G,
Blauwgeers H, van de Pol A, van Krieken JH and Meijer GA: Pathology
databanking and biobanking in The Netherlands, a central role for
PALGA, the nationwide histopathology and cytopathology data network
and archive. Cell Oncol. 29:19–24. 2007.PubMed/NCBI
|
|
48
|
Klufah F, Mobaraki G, Hausen AZ and
Samarska IV: Reactivation of BK polyomavirus in urine cytology is
not associated with urothelial cell carcinoma. Viruses.
12:14122020. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Katz MD, Serrano MF, Grubb RL III,
Skolarus TA, Gao F, Humphrey PA and Kibel AS: Percent microscopic
tumor necrosis and survival after curative surgery for renal cell
carcinoma. J Urol. 183:909–914. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Foria V, Surendra T and Poller DN:
Prognostic relevance of extensive necrosis in renal cell carcinoma.
J Clin Pathol. 58:39–43. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Kwon R, Argani P, Epstein JI, Lombardo KA,
Wang X, Pierorazio PM, Mehra R and Matoso A: Contemporary
characterization and recategorization of adult unclassified renal
cell carcinoma. Am J Surg Pathol. 45:450–462. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Clemmensen T, Matoso A, Graham T, Lai WS,
Rais-Bahrami S and Gordetsky J: Pathologic and clinical
characteristics of early onset renal cell carcinoma. Hum Pathol.
74:25–31. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Ross H, Martignoni G and Argani P: Renal
cell carcinoma with clear cell and papillary features. Arch Pathol
Lab Med. 136:391–399. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Sika-Paotonu D, Bethwaite PB, McCredie MR,
William Jordan T and Delahunt B: Nucleolar grade but not Fuhrman
grade is applicable to papillary renal cell carcinoma. Am J Surg
Pathol. 30:1091–1096. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Rabjerg M, Gerke O, Engvad B and Marcussen
N: Comparing World Health Organization/international society of
urological pathology grading and Fuhrman grading with the
prognostic value of nuclear area in patients with renal cell
carcinoma. Uro. 1:2–13. 2021. View Article : Google Scholar
|
|
56
|
Xiao Q, Yi X, Guan X, Yin H, Wang C, Zhang
L, Pang Y, Li M, Gong G, Chen D and Liu L: Validation of the World
Health Organization/international society of urological pathology
grading for Chinese patients with clear cell renal cell carcinoma.
Transl Androl Urol. 9:2665–2674. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Shuch B, Bratslavsky G, Linehan WM and
Srinivasan R: Sarcomatoid renal cell carcinoma: A comprehensive
review of the biology and current treatment strategies. Oncologist.
17:46–54. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Park JY, Lee JL, Baek S, Eo SH, Go H, Ro
JY and Cho YM: Sarcomatoid features, necrosis, and grade are
prognostic factors in metastatic clear cell renal cell carcinoma
with vascular endothelial growth factor-targeted therapy. Hum
Pathol. 45:1437–1444. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Delahunt B, Srigley JR, Amin MB, Billis A,
Camparo P, Evans AJ, Fleming S, Griffiths D, Lopez-Beltran A,
Martignoni G, et al: Invasive carcinoma of renal tubular origin,
histopathology reporting guide. 1st edition. International
Collaboration on Cancer Reporting; Sydney; Australia: 2017
|
|
60
|
Bengió RG, Arribillaga LC, Epelde J,
Orellana S, Montedoro A, Bengió V, Cordero E and Guevara M:
Evaluation of microvascular invasion as a prognostic factor in the
progression of non-metastatic renal cancer. Cent European J Urol.
71:386–390. 2018.PubMed/NCBI
|
|
61
|
Lang H, Lindner V, Letourneux H, Martin M,
Saussine C and Jacqmin D: Prognostic value of microscopic venous
invasion in renal cell carcinoma: Long-term follow-up. Eur Urol.
46:331–335. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Roos FC, Weirich J, Victor A, Elsässer A,
Brenner W, Biesterfeld S, Hampel C and Thüroff JW: Impact of
several histopathological prognosticators and local tumour
extension on oncological outcome in pT3b/c N0M0 renal cell
carcinoma. BJU Int. 104:461–469. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Sevinç M, Kirkali Z, Yörükoğlu K, Mungan U
and Sade M: Prognostic significance of microvascular invasion in
localized renal cell carcinoma. Eur Urol. 38:728–733. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Van Poppel H, Vandendriessche H, Boel K,
Mertens V, Goethuys H, Haustermans K, Van Damme B and Baert L:
Microscopic vascular invasion is the most relevant prognosticator
after radical nephrectomy for clinically nonmetastatic renal cell
carcinoma. J Urol. 158:45–49. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Hermanek P, Scheibe O, Spiessl B and
Wagner G: TNM classification of malignant tumors: The new 1987
edition. Rontgenblatter. 40:2001987.(In German). PubMed/NCBI
|
